Aging
Navigate
Back to articleFigure 4(4 of 8)
100%
Figure 4
Figure 4.The variation trend of chemokines after SARS-CoV treatment 12h, 24h and 48h respectively. (A) Ccl2; (B) Ccl3; (C) Ccl5; (D) Cxcl3; (E) Cxcl5; (F) Cxcl10.
Figure 4 — Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2 | Aging